Editor's note: Be sure to read the other articles in this series:
- Consolidated Appropriations Act deep dive: Impact on Families First Coronavirus Relief Act's paid leave provisions
- Consolidated Appropriations Act deep dive: Health and dependent care flexible spending accounts
- Consolidated Appropriations Act deep dive: The Paycheck Protection Program and Employee Retention Tax Credit
- Consolidated Appropriations Act deep dive: Surprise balance billing
While much of the Consolidated Appropriations Act of 2021 addresses issues directly related to the COVID-19 pandemic, the law also contains many sections covering other health policy issues. One of these is Title II, Section 203, which aims to improve compliance with the non-quantitative treatment limitation requirements outlined in the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA).
This part of the new law requires group health plans and individual and group health insurance carriers to perform and document comparative analyses of how every plan design they offer applies non-quantitative treatment limitations for mental health and substance use disorders. All applicable plans will need to be prepared to make this and other parity compliance information available to the federal Departments of Health and Human Services (HHS) and Labor (DOL) upon request.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
